Dashboard
Curated content
Companies
Stats & Insights
Sectors
Investors
Transactions
Multiples
More organizations
News
Deep Dives
Knowledge base
Companies
Thymmune Therapeutics
Save
Thymmune Therapeutics
Verified
Launch date
2019
Employees
11-50 people
Market cap
-
Net debt
-
Enterprise valuation
$28—42m
(Dealroom.co estimates Mar 2023.)
Cambridge Massachusetts (HQ)
https://www.thymmune.com/
https://www.linkedin.com/company/thymmune/
B2B
manufacturing
commission
health
biotechnology
hard tech
biotechnology
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Thymmune Therapeutics funding
Thymmune Therapeutics investors
Edit
Get premium to view all results
Date
Investors
Amount
Round
Apr 2022
N/A
$0.0
round
Mar 2023
investor investor investor investor investor investor investor investor
$0.0
round
Sep 2023
*
Arpa-h
$37.0m
Grant
Total Funding
000k
Related Content
Recent News about Thymmune Therapeutics
Edit
